Browsing Tag
Inc.
380 posts
Merck’s KEYTRUDA + WELIREG combo shows major disease-free survival benefit in clear cell renal cell carcinoma after surgery
Find out how Merck’s KEYTRUDA + WELIREG combo improved disease-free survival after kidney cancer surgery and what it means for the oncology market.
October 28, 2025
Merck and Eisai announce major win as Welireg plus Lenvima delays progression in advanced renal cell carcinoma
Find out how Merck and Eisai’s Welireg + Lenvima combo redefines kidney cancer care after immunotherapy and what this major Phase 3 win means for investors.
October 28, 2025
Aeluma makes bold move to boost in-house semiconductor production with new equipment buy
Find out how Aeluma’s latest equipment acquisition could redefine its semiconductor manufacturing strategy and accelerate commercialization.
October 28, 2025
Merck’s kidney cancer breakthrough hits one target—Will it be enough to change how doctors treat RCC?
Merck and Eisai’s new kidney cancer combination met a key Phase 3 goal. Discover what it means for patients, investors, and the oncology landscape.
October 28, 2025
Will mobile-first AI give Medallia the edge in real-time customer feedback battles?
Medallia brings real-time AI to frontline workers with mobile-first upgrades—transforming how enterprises act on customer feedback. Discover what’s new.
October 24, 2025
Half of platinum-resistant ovarian cancer patients respond to Raludotatug deruxtecan in REJOICE-Ovarian01 trial
Find out how Raludotatug deruxtecan achieved a 50 % response rate in platinum-resistant ovarian cancer and what it means for future ADC therapies.
October 20, 2025
Will Navan’s IPO be the next travel-tech breakout or just another high-burn unicorn testing public markets?
Navan targets $6.45 billion valuation in upcoming Nasdaq listing, but faces regulatory delays, valuation compression, and profitability pressures
October 17, 2025
Will Washington blink first? Trump dangles a health-care deal if Democrats end the shutdown
Trump says he’ll discuss ACA subsidies with Democrats—but only after reopening government. Find out what’s at stake for consumers and insurers.
October 7, 2025
Amazon Grocery launch sparks fresh battle with Costco’s Kirkland and Walmart’s Great Value
Amazon rolls out a new private label brand to challenge Costco’s Kirkland and Walmart’s Great Value. Find out how this move could reshape grocery retail.
October 1, 2025
Are AI-discovered vaccines the next big frontier in pharma?
AI-discovered vaccines are moving from hype to reality. See how Evaxion, BioNTech, DIOSynVax and Baseimmune are reshaping discovery—and why big pharma is buying.
September 30, 2025